INTRODUCTION
Quantitation is essential for detection of large genomic duplications or deletions. Quantitative PCR has been achieved with external controls (1-3), competitive PCR with an internal dosage control (4) (5) (6) , and multiplex PCR (7) (8) (9) (10) (11) .
Quantitation of gene dosage remains a challenge, and it is known that multiplex PCR is sensitive to DNA quality (12, 13) . Impurities in DNA samples can exert their effects by altering the efficiency of amplification in the exponential phase and the plateau phase of one or more segments. In addition, point mutations downstream of the primer within the amplified region can inhibit amplification (14, 15) .
Robust dosage PCR (RD-PCR), a duplex quantitative PCR, was developed recently for the rapid and accurate detection of large heterozygous deletions and duplications (16, 17) . RD-PCR amplifies an endogenous internal control and target locus. The internal control has a known gene copy number per cell, while the target has an unknown dosage number per cell. The ratio of yield (ROY) is directly proportional to the ratio of the two input templates, so the copy number of the target gene can be obtained from the ROY and the known copy number of the internal control.
When multiple RD-PCR assays were developed, significant inter-individual variation occurred in two regions of the MECP2 gene. This variation was easily eliminated by heating the genomic DNA samples in 2× TE solution (20 
Elimination of locus-specific inter-individual variation in quantitative PCR

MATERIALS AND METHODS
Genomic DNA Samples
Genomic DNA was prepared from peripheral blood by the Puregene ® DNA Isolation kit (Gentra, Minneapolis, MN, USA), the standard phenol/chloroform protocol (18) , or the Super Quick Gene DNA extraction kit (Analytical Genetic Testing Center, Denver, CO, USA). The samples were extracted and stored at -20°C for 0-10 years.
Sample Pretreatment
DNA concentrations were measured by UV spectrophotometer at 260 nm and adjusted to a working concentration of 30 ng/µL in 2× TE. Note that 1× TE eliminates the inter-individual variation, but decrease the yields. DNA samples were pretreated at 90°C for 10 min and then placed at 4°C until the RD-PCR assays were performed. Other pretreatments were also performed (see Results and Discussion).
RD-PCR Assay
Six assays were designed (Table 1) according to Liu et al. (16) except for a shorter 5′ universal tail (5′-GGCCAAGTGT-3′). Each assay contained a target and an internal control segment. The assays were divided into two groups (group I and II) depending on whether the ATM or FUT gene was used as the autosomal control segment. Group I had four assays with GC contents ranging from 36.6% to 55%; group II had two assays with GC content of 61% and 56%.
The PCR mixtures contained a total volume of 25 μL: 1× Expand™ High 
Quantitation
Twelve microliters of PCR product were electrophoresed through a standard 2% agarose gel. Gels were stained in 0.2 μg/mL ethidium bromide for 1 h and scanned by the Typhoon™ 9410 Imager (Amersham Biosciences, Piscataway, NJ, USA) with the following parameters: focal plane = +3 mm; laser wavelength = green, 532 nm; emission filter = 610 BP 30; photomultiplier voltage = 600 V; pixel size = 100 µm; and sensitivity = normal.
ImageQuant™ software (Amersham Biosciences) was used to quantitate the PCR yield. Net signal of a band was obtained by subtracting the local background. The ROY is calculated by dividing the target net signal by the internal control net signal. For normalization, the ROY of the patient sample was divided by the average ROY of the females (17) .
RESULTS AND DISCUSSION
Locus-Specific Assay Variability
Six RD-PCR assays were performed using genomic DNA samples from seven males and seven females. In assays 1 and 2, significant interindividual variation occurred ( Figure  1A ).
When exon 2 of the MECP2 gene was amplified along with exon 12 of the ATM gene as a control (assay 1), the product yields of the target were reduced among individual genomic DNA samples, while the yield of the control was similar among samples. ROYs varied from 0.30 to 1.03 in female samples and 0.20 to 0.40 in male samples ( Figure 1A) . The standard deviations were 0.28 in female samples and 0.06 in male samples. For SHORT TECHNICAL REPORTS exon 3 of the MECP2 gene with the internal control of exon 12 of the ATM gene (assay 2), similar variation was observed ( Figure 1A) .
The inter-individual variability in the other assays 3-6 was low and not significant. As an example, the ROYs in assay 3 are listed in Figure 1 .
The assay variability seen in assays 1 and 2 occurred with genomic DNA extracted by either the Puregene DNA Isolation kit, the phenol/chloroform method, or the Super Quick Gene DNA extraction kit (data not shown).
Elimination of Locus-Specific Assay Variability
Initially, treatment of genomic DNA with Proteinase K at 56°C for 16 h eliminated the assay variability. Subsequent experiments revealed that simply incubating the sample at 90°C for 10 min eliminated assay variability, while the variability was not eliminated by RNase treatment, treatment at 56°C at 2 or 16 h, or with membrane filtration (Table 2) . After heat treatment in 2× TE at 90°C for 10 min, the genomic DNA samples were amplified by RD-PCR assays 1-6. The product yields of the target and control were quantitated, and the ROYs were then obtained. The average ROYs and standard deviation of each assay before and after the heat treatment are listed in Figure 1C .
Assay deviations were due to variable lower product yield of the MECP2 targets 
SHORT TECHNICAL REPORTS
and not the control segment. In RD-PCR assay 1, the product yields of the target were greatly increased by heat treatment, up to 3.46-fold, among individual genomic DNA samples. The yield of the control changes little, varying from 0.83-to 1.09-fold (Table 3) . Thus, ROYs were greatly increased to 0.52-0.67 in the male samples and 0.98-1.12 in the female samples ( Figure 1B) . The standard deviations of ROY were 0.05 in the male samples and 0.04 in the female samples, showing that heat treatment makes the assay more consistent and eliminates the inter-individual variation. Similar results were observed in assay 2 ( Figure 1B) . The same experiments were repeated to confirm the results in both assays. Similar results were obtained from genomic DNAs extracted by the phenol/chloroform method and the Super Quick Gene DNA extraction kit (data not shown). Heat treatment has also been used in eight subsequent assays; all worked well with little interindividual variation despite the use of samples extracted with the Puregene, phenol/chloroform, and Super Quick Gene methods (17) .
The mechanism of the inter-individual variation and its elimination is unclear. When genomic DNA was serially diluted by 2-, 4-, 8-, 16-, 32-, and 64-fold and amplified for 30 cycles in assay 1, the anomalous ratios remained, suggesting that the inhibition was closely associated with the genomic DNA. We speculate that certain high-affinity DNA binding proteins may remain after extraction and may exert a subtle effect that is detected when dosage analysis is performed.
Conceivably, other genomic regions might resist 90°C for 10 min. More work is needed to determine whether longer incubation with or without proteinase or other enzymatic treatment is necessary to remove inhibitors from certain regions. Ultimately, a pretreatment of DNA may facilitate robust multiplexed amplification throughout the genome. From a practical protocol of view, it may be prudent to treat with Proteinase K under general hydrolytic conditions for 2 h, followed by 90°C heat inactivation in 2× TE solution, in case there are any bound proteins that can survive 90°C heat treatment.
In conclusion, heat treatment is necessary at some loci for accurate measurement of dosage by RD-PCR. It may be necessary for multiplex amplifiable probe hybridization (MAPH), multiplex ligation-dependent probe amplification (MLPA), and other methods of assessing dosage (19, 20) . Inhibitory amplification at certain segments also has implications for whole genome amplification techniques, such as multiple displacement amplification (MDA) and degenerate oligonucleotide prime PCR (DOP-PCR), in which quantitative representation might be an issue (21) (22) (23) . The general utility of pretreatment of multiplex PCR and the mechanism of heat pretreatment require further study.
